Absolutely good news seemingly-harmless. I'm in th
Post# of 148286
But yes, that approval says LL is cleared to wipe the deck of all these half azzed performing drugs.
With r&d, pre-clinical & clinical routes being taken, It's only a matter of time the market begins to see LL matches the peer reviews, & even non affiliated doctors, talking about this newly approved, novel approach, of CCR5 Axis.
& we own the path for next 19 yrs..... : )
Expecting along the way multiple & out of the box developments on how LL, penetrates multiple markets.
We're getting there bubbe....we're getting there. : )